August 11, 2026 06:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jharkhand student protest turns tense: Water cannons, lathicharge after Assembly march barricades breached | ‘Mother tongue is as pure as one's mother’: Vijay-led Tamil Nadu government makes Tamil Thaai Vazhthu mandatory in big language push | Indian envoy Kwatra cites US, UK laws to counter ‘myths’ around FCRA Bill | Jharkhand students march to assembly today: JPSC row escalates despite govt action | ‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute

Donald Trump announces new COVID-19 vaccine efforts

| @indiablooms | May 16, 2020, at 01:35 pm

Washington/Xinhua/UNI: US President Donald Trump announced on Friday two men will lead his administration's new effort for COVID-19 vaccine development.

Former pharmaceutical executive Moncef Slaoui and Army General Gustave Perna, the commander of United States Army Materiel Command, will lead "Operation Warp Speed," the new project to accelerate the vaccine development process for COVID-19.

The new project is a "historic partnership" of federal agencies, Trump told a noon briefing in the White House Rose Garden.

He said experts throughout the government have been evaluating 100 vaccine candidates. Among them, 14 vaccine candidates are showing promise.

Trump said he is hopeful a COVID-19 vaccine can be developed by the end of the year.

"Typically pharmaceutical companies wait to manufacture a vaccine until it has received all the regulatory approvals necessary, and this can delay the vaccine's availability to the public as much as a year, even more than that," Trump said.

The federal government will invest in manufacturing all of the top vaccine candidates before they are approved, according to Trump.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine, and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020," said Slaoui, former chair of the vaccines division at pharmaceutical GlaxoSmithKline, a British multinational pharmaceutical company headquartered in London.

He said that in addition to a vaccine, the new project will also focus on the development of medicines for those COVID-19 infected, as well as improving and "optimizing" diagnostic tests. 

Image: Pixabay

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.